Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA

Hepatology

Volumn 32, Issue 2, 2000, Pages 388-393

  Tanaka, Eiji ^a   Ohue, Chiharu ^b   Aoyagi, Katsumi ^b   Yamaguchi, Kenjiro ^b   Yagi, Shintaro ^b   Kiyosawa, Kendo ^a,c   Alter, Harvey J ^d  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJIREBIO INC   (Japan)

^c SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HEPATITIS C ANTIGEN; MONOCLONAL ANTIBODY; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG MONITORING; ENZYME IMMUNOASSAY; FEMALE; GENE AMPLIFICATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT OUTCOME; VIREMIA; VIRUS GENOME;

EID: 0033854022     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.9112     Document Type: Article

References (31)

1. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
2. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
3. Clinical outcomes after transfusion-associated hepatitis C
4. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis
5. The declining risk of post-transfusion hepatitis C virus infection
6. Detection of chronic hepatitis C virus infection by four diagnostic systems: First-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis
7. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting
8. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
9. Viral and host factors that contribute to the efficacy of interferon- alpha 2a therapy in patients with chronic hepatitis C
10. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay
11. High throughput assay for the simultaneous or separate detection of human immunodeficiency virus (HIV-1) and hepatitis C virus (HCV)
12. Reliability of polymerase chain reaction for detection of hepatitis C virus
13. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia
14. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)
15. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa
16. Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C - Clinical and virologic implications
17. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viremia in anti-HCV- positive patients
18. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen
19. Classification of chronic hepatitis: Diagnosis, grading and staging
20. Meeting report: International Autoimmune Hepatitis Group
21. The presentation and diagnosis of 100 patients with primary biliary cirrhosis
22. Current concepts: Primary sclerosing cholangitis
23. Typing hepatitis C virus by polymerase chain reaction with type- specific primers: Application to clinical surveys and tracing infectious sources
24. A proposed system for the nomenclature of hepatitis C viral genotypes
25. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi-institution analysis
26. Second generation of the automated Cobas Amplicor HCV Assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant
27. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis
28. Hepatitis C virus infection in post-transfusion hepatitis; An analysis with first- and second generation assays
29. Treatment of chronic hepatitis C with recombinant interferon alfa
30. Recombinant interferon alfa therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial
31. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C